Title |
Repurposed antiviral drugs for COVID-19 –interim WHO SOLIDARITY trial results
|
---|---|
Published in |
medRxiv, October 2020
|
DOI | 10.1101/2020.10.15.20209817 |
Authors |
WHO Solidarity trial consortium, Hongchao Pan, Richard Peto, Quarraisha Abdool Karim, Marissa Alejandria, Ana Maria Henao-Restrepo, César Hernández García, Marie-Paule Kieny, Reza Malekzadeh, Srinivas Murthy, Marie-Pierre Preziosi, Srinath Reddy, Mirta Roses Periago, Vasee Sathiyamoorthy, John-Arne Røttingen, Soumya Swaminathan, assume responsibility for the content and integrity of this article as the members of the Writing Committee |
X Demographics
The data shown below were collected from the profiles of 6,954 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 827 | 12% |
Spain | 361 | 5% |
United Kingdom | 357 | 5% |
France | 221 | 3% |
Japan | 219 | 3% |
Canada | 196 | 3% |
Peru | 119 | 2% |
India | 107 | 2% |
Australia | 73 | 1% |
Other | 1221 | 18% |
Unknown | 3253 | 47% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 5551 | 80% |
Scientists | 750 | 11% |
Practitioners (doctors, other healthcare professionals) | 525 | 8% |
Science communicators (journalists, bloggers, editors) | 127 | 2% |
Unknown | 1 | <1% |
Mendeley readers
The data shown below were compiled from readership statistics for 781 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 781 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 119 | 15% |
Researcher | 82 | 10% |
Other | 79 | 10% |
Student > Master | 77 | 10% |
Student > Ph. D. Student | 53 | 7% |
Other | 146 | 19% |
Unknown | 225 | 29% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 258 | 33% |
Pharmacology, Toxicology and Pharmaceutical Science | 59 | 8% |
Biochemistry, Genetics and Molecular Biology | 55 | 7% |
Chemistry | 27 | 3% |
Agricultural and Biological Sciences | 26 | 3% |
Other | 97 | 12% |
Unknown | 259 | 33% |